TABLE 1.
General characteristics of subjects.
| Variable |
|
Study groups |
|
F test | p | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Control |
PLWH on HAART |
Treatment-naïve PLWH |
|||||||||
| Mean ± s.d. | n | % | Mean ± s.d. | n | % | Mean ± s.d. | n | % | |||
| Mean age (years) | 30.0 ± 14 | - | - | 33.2 ± 15 | - | - | 32.5 ± 16 | - | - | 1.732 | 0.18 |
| Sex | |||||||||||
| Male | - | 29 | 49 | - | 22 | 36 | - | 21 | 36 | - | - |
| Female | - | 30 | 51 | - | 39 | 64 | - | 37 | 64 | - | - |
| Total | - | 59 | 100 | - | 61 | 100 | - | 58 | 100 | - | - |
| CD4 cell count | |||||||||||
| < 350 cells/µL | - | NA | - | - | 19 | - | - | 30 | - | - | - |
| ≥ 350 cells/µL | - | NA | - | 42 | - | - | - | 28 | - | - | - |
| ART | |||||||||||
| NRTI+NNRTI | - | NA | - | - | 48 | - | - | NA | - | - | - |
| NRTI+PI | - | NA | - | - | 13 | - | - | NA | - | - | - |
PLWH, people living with HIV; s.d., standard deviation; HAART, highly active antiretroviral treatment; NA, not applicable; ART, antiretroviral treatment; NRTI, nucleotide reverse transcriptase inhibitor; NNRTI, non-nucleotide reverse transcriptase inhibitor; PI, protease inhibitor.